Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020;152(1 & 2):122-123.
doi: 10.4103/0971-5916.290075.

Authors' response

Pranab Chatterjee  1 , Tanu Anand  2 , Kh Jitenkumar Singh  3 , Reeta Rasaily  4 , Ravinder Singh  5 , Santasabuj Das  6 , Harpreet Singh  7 , Ira Praharaj  8 , Raman R Gangakhedkar  8 , Balram Bhargava  9 , Samiran Panda  10
Affiliations
Comment

Authors' response

Pranab Chatterjee et al. Indian J Med Res. 2020.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None

Comment on

References

    1. Tirlangi P, Khan AR, Desai D, Soneja M. False reassurance or inadequate drug levels? IndianJ Med Res. 2020;152:121–2. - PMC - PubMed
    1. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, et al. Healthcare workers and SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19. IndianJ Med Res. 2020;151:459–67. - PMC - PubMed
    1. Jaume M, Yip MS, Cheung CY, Leung HL, Li PH, Kien F, et al. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway. J Virol. 2011;85:10582–97. - PMC - PubMed
    1. Hui KP, Cheung MC, Perera RA, Ng KC, Bui CH, Ho JC, et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: An analysis in ex vivo and in vitro cultures. Lancet RespirMed. 2020;8:687–95. - PMC - PubMed
    1. Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis. 2020 ciaa237. - PMC - PubMed